Exchange: NASDAQ·Updated 04:03 AM EDT
NBTX logo

NBTX Nanobiotix - ADR

$21.22
$0.08
(0.38%)
Pre-Market
Prev Close $21.30
EarningsMar 30
Mkt Cap$1.08B
Vol417.00

About NBTX

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
45

Neutral Sentiment

How do you feel about NBTX?

mktrdr59
$NBTX reaching the measured move price projections of two degrees at the Fib .618 retracement level
1

Advertisement|Remove ads.